Castleman disease, TAFRO, and related disease research group
Member
| Principal Investigator |
Kazuyuki Yoshizaki |
|---|
| Research member |
Sadao Aoki |
|---|
| Yasuhito Ishigaki |
| Makoto Ide |
| Kazuko Uno |
| Shinichiro Okamoto |
| Atsushi Kawakami |
| Hiroshi Kawabata |
| Shigeo Nakamura |
| Yasufumi Masaki |
| Masao Mizuki |
| Shingo Yano |
| |
| Research Collaborator |
Soichirou Ikushima |
|---|
| Yasunori Ueda |
| Mitsuhiro Kawano |
| Kitoh Akihiko |
| Nozomu Kurose |
| Tomohiro Koga |
| Toshiyuki Kojima |
| Keigo Setoguchi |
| Kazue Takai |
| Norifumi Tsukamoto |
| Shinichirou Tsunoda |
| Yukihiro Tokumine |
| Chiaki Nakaseko |
| Sumiyuki Nishida |
| Hiroshi Fujiwara |
| Shoko Matsui |
| Katsuhiro Miura |
| Minoru Mizutani |
| Shinichi Murayama |
| Hiroshi Yamamoto |
| Hajime Yoshifuji |
Research achievement
- Koga T, Sumiyoshi R, Kawakami A and Yoshizaki K. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. Modern Rheumatology. 2018 Oct; DOI: 10.1080/14397595.2018.1532383
- Frits van Rhee, Peter Voorhees, Angela Dispenzieri, Alexander Fosså, Gordan Srkalovic, Makoto Ide, Nikhil Munshi, Stephen Schey, Matthew Streetly, Sheila K. Pierson, Helen L. Partridge, Sudipto Mukherjee, Dustin Shilling, Katie Stone, Amy Greenway, Jason Ruth, Mary Jo Lechowicz, Shanmuganathan Chandrakasan, Raj Jayanthan, Elaine S. Jaffe, Heather Leitch, Naveen Pemmaraju, Amy Chadburn, Megan S. Lim, Kojo S. Elenitoba-Johnson, Vera Krymskaya, Aaron Goodman, Christian Hoffmann, Pier Luigi Zinzani, Simone Ferrero, Louis Terriou, Yasuharu Sato, David Simpson, Raymond Wong, Jean-Francois Rossi, Sunita Nasta,30 Kazuyuki Yoshizaki, Razelle Kurzrock, Thomas S. Uldrick, Corey Casper, Eric Oksenhendler, and David C. Fajgenbaum
International, Evidence-based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease. Blood First Edition Paper, prepublished online September 4, 2018; DOI 10.1182/blood-2018-07-862334
- Fujimoto S, Koga T, Kawakami A, Kawabata H, Okamoto S, Mizuki M, Yano S, Ide M, Uno K, Yagi K, Kojima T, Mizutani M, Tokumine Y, Nishimoto N, Fujiwara H, Nakatsuka SI, Shiozawa K, Iwaki N, Masaki Y, Yoshizaki K. Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan. Mod Rheumatol. 2017 Sep; 7:1-7.
- Koga T, Fujimoto S, Kawakami A, Kawabata H, Masaki Y, Kishimoto T, Yoshizaki K. Therapeutic outlook for Castleman’s disease: prospects for the next decade. Expert Opinion on Orphan Drugs. 2017 Jul; 5(8):633-640.
- Yoshizaki K, Okamoto S, Kawabata H, et al: A reference guide for management of Castleman disease. Rinsho Ketsueki 58: 97-107, 2017 http://doi.org/10.11406/rinketsu.58.97
- Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi , JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017 Mar 23; 129(12): 1646–1657. Prepublished online 2017 Jan 13. doi: 10.1182/blood-2016-10-746933.